A Study of Belzutifan in Adolescent Participants With Solid Tumors (MK-9999-01E/LIGHTBEAM-U01) | MicrobiomeTrials← Back to trialsNCT07700758
A Study of Belzutifan in Adolescent Participants With Solid Tumors (MK-9999-01E/LIGHTBEAM-U01)
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-10-13Est. Completion: 2034-01-02
Enrollment target: 15 participants Locations- University of Iowa ( Site 5017), Iowa City, Iowa, United States
- UZ Gent ( Site 5428), Ghent, Oost-Vlaanderen, Belgium
- Seoul National University Hospital-Pediatrics ( Site 5972), Seoul, South Korea
- Hospital Infantil Universitario Nino Jesus ( Site 5715), Madrid, Spain
Other microbiome trials you might be interested in
Lung NeoplasmsNeoadjuvant TherapyImmunotherapyMinimal Residual Disease
This study is a prospective single-arm clinical trial targeting patients with stage IB-IIIA non-small cell lung cancer (…
Beijing, ChinaEst. completion Oct 31, 2027
Lung Cancer
This study aims to evaluate whether femtosecond laser imaging combined with FastLung AI model can provide intraoperative…
Shanghai, ChinaEst. completion Oct 30, 2026
Colorectal NeoplasmsNeoplasmsIntrahepatic CholangiocarcinomaAdrenocortical CarcinomaMetastasis, Neoplasm
Background:
Cancers that begin in the colon, adrenal glands, or bile ducts may spread to the liver. These liver tumors …
Bethesda, United StatesEst. completion Dec 31, 2029